Abstract:Human-specific lncRNA GATA2AS is a regulator of erythroid differentiation GATA2AS is a novel GATA2 and HBG activator through distinct mechanisms LncRNAs are extensively expressed in eukaryotic cells and have been revealed to be important for regulating cell differentiation. Many lncRNAs have been found to regulate erythroid differentiation in the mouse. However, given the low sequence conservation of lncRNAs between mouse and human, our understanding of lncRNAs in human erythroid differentiation remains incomplete. LncRNAs are often transcribed opposite to protein coding genes and regulate their expression. Here we characterized a human erythrocyte-expressed lncRNA, GATA2AS, which is transcribed opposite to erythroid transcription regulator GATA2. GATA2AS is a 2080 bp-long, primarily nuclear-localized non-coding RNA that is expressed in erythroid progenitor cells and decreases during differentiation. Knockout of GATA2AS in human HUDEP2 erythroid progenitor cells using CRISPR-Cas9 genome editing to remove the transcription start site accelerated erythroid differentiation and dysregulated erythroblast gene expression. We identified GATA2AS as a novel GATA2 and HBG activator. Chromatin Isolation by RNA Purification (ChIRP) showed that GATA2AS binds to thousands of genomic sites and colocalizes at a subset of sites with erythroid transcription factors including LRF and KLF1. RNA-pulldown and RIP confirmed interaction between GATA2AS and LRF and KLF1. ChIP-sequencing showed that knockout of GATA2AS reduces binding of these transcription factors genome wide. ATAC-seq and H3K27ac ChIP-seq showed that GATA2AS is essential to maintain the chromatin regulatory landscape during erythroid differentiation. Knockdown of GATA2AS in human primary CD34+ cells mimicked results in HUDEP2 cells. Overall, our results implicate human-specific lncRNA GATA2AS as a regulator of erythroid differentiation by influencing erythroid transcription factor binding and the chromatin regulatory landscape.

Divergent lncRNA GATA3-AS1 Regulates GATA3 Transcription in T-Helper 2 Cells

Distinct Functions for the Transcription Factors GATA-3 and ThPOK During Intrathymic Differentiation of CD4+ T Cells

Ash1l and lnc-Smad3 coordinate Smad3 locus accessibility to modulate iTreg polarization and T cell autoimmunity

Differential Expression of the Transcription Factor GATA3 Specifies Lineage and Functions of Innate Lymphoid Cells.

The Transcription Factor GATA3 is Critical for the Development of All IL-7Rα-expressing Innate Lymphoid Cells.

GATA-3 regulates the development of ILC3 subsets at multiple stages (LYM2P.721)

Bcl11b, A Novel Gata3-Interacting Protein, Regulates T-Helper-2-Cell Differentiation and Function

Long noncoding RNA GATA2AS influences human erythropoiesis by transcription factor and chromatin landscape regulation

The Essential Role of Gata3 in Th2 Cell Differentiation

Physical and Functional Interaction Between GATA-3 and Smad3 Allows TGF-β Regulation of GATA Target Genes

GATA-3 is an important transcription factor for regulating human NKG2A gene expression

Coordinate Regulation of TCR signaling, Notch, and Gata3 in T Cell Development (138.27)

Bcl11b, a Novel GATA3-interacting Protein, Suppresses Th1 While Limiting Th2 Cell Differentiation

Increased level of GATA3-AS1 long non-coding RNA is correlated with the upregulation of GATA3 and IL-4 genes in multiple sclerosis patients

Transcription factor GATA4 drives RNA polymerase III-directed transcription and transformed cell proliferation through a filamin A/GATA4/SP1 pathway

GATA6-AS1 Regulates GATA6 Expression to Modulate Human Endoderm Differentiation.

ScRNA-seq Analyses Define the Role of GATA3 in iNKT Cell Effector Lineage Differentiation

The STAT3-Binding Long Noncoding RNA lnc-DC Controls Human Dendritic Cell Differentiation

Murine and human T-lymphocyte GATA-3 factors mediate transcription through a cis-regulatory element within the human T-cell receptor delta gene enhancer

GATA3 induces the pathogenicity of Th17 cells via regulating GM-CSF expression

GATA-3 is a proto-oncogene in T-cell lymphoproliferative neoplasms